98 related articles for article (PubMed ID: 8493451)
1. Circulating markers and growth factors as prognosticators in men with advanced tongue cancer.
Bhatavdekar JM; Patel DD; Vora HH; Balar DB
Tumour Biol; 1993; 14(1):55-8. PubMed ID: 8493451
[TBL] [Abstract][Full Text] [Related]
2. Circulating prolactin and tumoral prolactin receptors in men with tongue cancer: a preliminary study.
Patel DD; Bhatavdekar JM; Vora HH; Balar DB
Eur J Surg Oncol; 1994 Apr; 20(2):155-9. PubMed ID: 8181582
[TBL] [Abstract][Full Text] [Related]
3. Tumor markers in patients with advanced breast cancer as prognosticators: a preliminary study.
Bhatavdekar JM; Patel DD; Karelia NH; Vora HH; Ghosh N; Shah NG; Balar DB; Trivedi SN
Breast Cancer Res Treat; 1994; 30(3):293-7. PubMed ID: 7981447
[TBL] [Abstract][Full Text] [Related]
4. Circulating prolactin and TPS in monitoring the clinical course of male patients with metastatic tongue cancer: a preliminary study.
Bhatavdekar JM; Patel DD; Vora HH; Balar DB
Anticancer Res; 1993; 13(1):237-40. PubMed ID: 7682801
[TBL] [Abstract][Full Text] [Related]
5. Prolactin: its role in advanced tongue cancer.
Bhatavdekar JM; Patel DD; Vora HH; Shah NG; Karelia NH; Ghosh N; Balar DB
J Surg Oncol; 1994 Oct; 57(2):115-20. PubMed ID: 7934062
[TBL] [Abstract][Full Text] [Related]
6. Prolactin as a local growth promoter in patients with locally advanced tongue cancer: GCRI experience.
Bhatavdekar JM; Patel DD; Vora HH; Shah NG; Chikhlikar PR; Ghosh N
Head Neck; 2000 May; 22(3):257-64. PubMed ID: 10748449
[TBL] [Abstract][Full Text] [Related]
7. The Diagnostic and Prognostic Value of Tumor Markers (CEA, SCC, CYFRA 21-1, TPS) in Head and Neck Cancer Patients.
Barak V; Meirovitz A; Leibovici V; Rachmut J; Peretz T; Eliashar R; Gross M
Anticancer Res; 2015 Oct; 35(10):5519-24. PubMed ID: 26408719
[TBL] [Abstract][Full Text] [Related]
8. Circulating epidermal growth factor (EGF) and insulin-like growth factor-I (IGF-I) in patients with epithelial ovarian carcinoma.
Shah NG; Bhatavdekar JM; Doctor SS; Suthar TP; Balar DB; Dave RS
Neoplasma; 1994; 41(5):241-3. PubMed ID: 7854492
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological and prognostic significance of preoperative serum epidermal growth factor levels in patients with oral squamous cell carcinoma.
Lin JS; Sun FJ; Lin PY; Chang KW; Yang CC; Liu CJ
Int J Oral Maxillofac Surg; 2018 Oct; 47(10):1236-1242. PubMed ID: 29843953
[TBL] [Abstract][Full Text] [Related]
10. The relationship between Glasgow Prognostic Score and serum tumor markers in patients with advanced non-small cell lung cancer.
Jiang AG; Chen HL; Lu HY
BMC Cancer; 2015 May; 15():386. PubMed ID: 25956656
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of cell motility activation factors in patients with tongue squamous cell carcinoma.
Endo K; Shirai A; Furukawa M; Yoshizaki T
Hum Pathol; 2006 Aug; 37(8):1111-6. PubMed ID: 16867875
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of EGFR and hyaluronan in tongue cancer and the development of regional recurrence in patients initially diagnosed N0.
Lindell Jonsson E; Nylander K; Hallén L; Laurell G
Acta Otolaryngol; 2017 Aug; 137(8):877-882. PubMed ID: 28355940
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of miRNA-424: a sign of field cancerisation in clinically normal tongue adjacent to squamous cell carcinoma.
Boldrup L; Coates PJ; Laurell G; Wilms T; Fahraeus R; Nylander K
Br J Cancer; 2015 May; 112(11):1760-5. PubMed ID: 25965165
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of biomarkers in squamous cell carcinoma of the tongue: multivariate analysis.
Vora HH; Shah NG; Patel DD; Trivedi TI; Chikhlikar PR
J Surg Oncol; 2003 Jan; 82(1):34-50. PubMed ID: 12501167
[TBL] [Abstract][Full Text] [Related]
15. The prognostic value of hypoxia markers in T2-staged oral tongue cancer.
Roh JL; Cho KJ; Kwon GY; Ryu CH; Chang HW; Choi SH; Nam SY; Kim SY
Oral Oncol; 2009 Jan; 45(1):63-8. PubMed ID: 18620902
[TBL] [Abstract][Full Text] [Related]
16. Independent prognostic value of preoperative serum markers CA 242, specific tissue polypeptide antigen and human chorionic gonadotrophin beta, but not of carcinoembryonic antigen or tissue polypeptide antigen in colorectal cancer.
Carpelan-Holmström M; Haglund C; Lundin J; Alfthan H; Stenman UH; Roberts PJ
Br J Cancer; 1996 Sep; 74(6):925-9. PubMed ID: 8826859
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance and function of mammalian target of rapamycin in tongue squamous cell carcinoma.
Li SH; Chien CY; Huang WT; Luo SD; Su YY; Tien WY; Lan YC; Chen CH
Sci Rep; 2017 Aug; 7(1):8178. PubMed ID: 28811537
[TBL] [Abstract][Full Text] [Related]
18. The expression of vascular endothelial growth factor-A and -C, and receptors 1 and 3: correlation with lymph node metastasis and prognosis in tongue squamous cell carcinoma.
Tanigaki Y; Nagashima Y; Kitamura Y; Matsuda H; Mikami Y; Tsukuda M
Int J Mol Med; 2004 Sep; 14(3):389-95. PubMed ID: 15289890
[TBL] [Abstract][Full Text] [Related]
19. [Correlation between prognosis and cell proliferation, apoptosis in squamous cell carcinoma of tongue].
Yang YP; Qing HY; Cao Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2003 Jan; 38(1):31-4. PubMed ID: 12760773
[TBL] [Abstract][Full Text] [Related]
20. Does securin expression have significance in prognostication of oral tongue cancer? A pilot study.
Heikkinen I; Almangush A; Hagström J; Bello IO; Kauppila JH; Mäkinen LK; Haglund C; Nieminen P; Salo T; Leivo I
Eur Arch Otorhinolaryngol; 2016 Nov; 273(11):3905-3911. PubMed ID: 27091335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
